Breaking news

Institute Of Neurology And Genetics Cyprus Inaugurates Landmark Research Facility

The Cyprus Institute of Neurology and Genetics inaugurated a new research building, its largest infrastructure project to date. The facility expands capacity for biomedical research and education.

The project was funded by the European Investment Bank and the Republic of Cyprus. This structure marks the first use of such financing for a research project in the country.

Official Inauguration Signals A New Era In Innovation

Opening marks the expansion of research infrastructure in Cyprus. The institute aims to increase capacity in biomedical and genetic research. The facility supports laboratory work, education and collaboration. Expansion aligns with national efforts to develop research capabilities.

Strategic Investment In Cutting-Edge Research

Funded jointly by the European Investment Bank and the Republic of Cyprus, the project marks the nation’s first research initiative to secure such financial backing. This investment underscores the country’s commitment to elevating scientific exploration and fostering global competitiveness in health research.

World-Class Facilities Designed For Excellence

The new facility spans approximately 11,000 square meters, purposefully designed to accommodate pioneering research teams working on critical health issues. Equipped with state-of-the-art laboratories, advanced technological tools, and modern educational spaces, the building has been constructed to meet international standards akin to leading research centers around the globe.

Enhanced Research And Collaborative Opportunities

The upgraded infrastructure is set to bolster the Institute’s research output significantly. With improved facilities, the building is expected to cultivate critical partnerships and attract a growing number of postgraduate students, ensuring that the benefits of increased research capacity positively impact patients and the broader public.

Leadership Perspective And Future Impact

Professor Leonidas Fylaktou, the General Executive and Medical Director of INGK, expressed his pride in the project. “The official inauguration of our new building fills us with immense pride and joy,” he stated. “This landmark project not only sets the stage for accelerated research but also lays the groundwork for tangible benefits to patients and citizens alike.”

A Beacon Of Biomedical Innovation

The institute continues to position itself as a research center in Cyprus and the region. New facility adds to existing infrastructure and capabilities. Future impact will depend on research output and partnerships. Development reflects continued investment in biomedical research.

Bank of Cyprus Upgrade Signals Fresh Optimism For Greek And Cypriot Banks

Regional Banks Enter A More Favorable Cycle

Bank of Cyprus and Eurobank are well positioned to benefit from a renewed re-rating of Greek and Cypriot bank stocks, according to Cyprus-based investment firm Roemer Capital, which upgraded Bank of Cyprus to a buy rating and reaffirmed its positive view on Eurobank.

The firm cited easing geopolitical tensions, resilient economic growth in Greece and Cyprus, lower funding costs and Greece’s expected transition to developed-market status as the main factors supporting the sector.

Roemer Capital also lowered its cost of equity assumptions, updated its forecasts following first-quarter 2026 results and extended its valuation horizon to the end of 2027, raising target prices across its banking coverage.

Bank Of Cyprus Gets The Largest Upgrade

Bank of Cyprus received the biggest revision, with Roemer Capital upgrading the stock from hold to buy and setting a target price of €11.10, implying potential total upside of 27%.

The firm highlighted the bank’s strong capital generation, profitability and projected 100% dividend payout, describing it as the strongest capital-return story among the banks under coverage. Roemer Capital maintained its buy rating on Eurobank, assigning a target price of €4.90 and forecasting potential upside of 28%. The report said the bank is well placed to benefit from loan growth, improving operating performance and merger-and-acquisition synergies.

National Bank of Greece and Piraeus Bank also retained buy ratings, with expected returns ranging from 25% to 36%. Optima Bank was upgraded to buy, while Alpha Bank remained at hold on valuation grounds.

Why Growth Still Sets The Region Apart

According to Roemer Capital, Greek and Cypriot banks continue to benefit from stronger economic fundamentals than many western European peers. The report pointed to faster economic growth, healthier balance sheets, low levels of non-performing exposures, capital ratios approaching 20% and strong customer deposit bases.

Analysts expect performing loans across the sector to grow at a compound annual rate of 6% to 8% through 2028, supported by private investment, digitalisation, green manufacturing, supply-chain expansion and a gradual recovery in household lending.

The report also said the conclusion of lending under the EU Recovery and Resilience Facility is unlikely to materially affect credit growth, as banks have already shifted back towards traditional commercial lending. Roemer Capital expects Euribor to remain between 2.2% and 2.5%, a level it believes should support both lending activity and net interest margins.

Geopolitics, Valuation And Market Structure Support The Case

The report said improving geopolitical conditions have strengthened the investment outlook, noting that Brent crude prices have largely returned to pre-war levels while Greek government bond yields have stabilised at around 3.5%. Although geopolitical risks remain, Roemer Capital believes the likelihood of a major inflationary shock or significant pressure on bank profitability has eased.

Another important catalyst identified by the firm is Greece’s expected promotion to developed-market status by FTSE Russell, STOXX and MSCI over the coming months.

According to the report, the reclassification should improve liquidity and attract a broader base of international investors. Roemer Capital also said Euronext’s acquisition of the Athens Exchange is expected to strengthen market infrastructure and increase international visibility, particularly for Bank of Cyprus and Optima Bank.

The firm noted that Bank of Cyprus has already benefited from its Athens listing, with average daily trading value increasing from less than €400,000 before its September 2024 move to nearly €6 million afterwards.

Economic Momentum Remains A Core Tailwind

Roemer Capital said both Greece and Cyprus have moved beyond post-crisis recovery and are now supported by private-sector-led growth. For Cyprus, the report highlighted recent tax reform and efforts to simplify the legal and regulatory framework, while also noting that limited foreign banking competition continues to support domestic lenders.

Overall, Roemer Capital expects Greek and Cypriot banks to remain well-positioned for profitable loan growth over the coming years.

The Future Forbes Realty Global Properties
Uol
Aretilaw firm
eCredo

Become a Speaker

Become a Speaker

Become a Partner

Subscribe for our weekly newsletter